<https://rdf.molmedb.upol.cz/reference/ref4630> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM497596>,
		<https://identifiers.org/molmedb/MM497596.1>;
	<http://purl.org/ontology/bibo/pmid> "17983746"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method91>,
		<https://rdf.molmedb.upol.cz/interaction/membrane64>;
	<http://purl.org/dc/terms/bibliographicCitation> "Kitas EA, Galley G, Jakob-Roetne R, Flohr A, Wostl W, Mauser H, Alker AM, Czech C, Ozmen L, David-Pierson P, Reinhardt D, Jacobsen H.: Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors. Bioorg Med Chem Lett, Volume 18 (1), 2008"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2007.10.074"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1031544> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4630> .